Ads
related to: Latest Treatment Copd
Search results
Earnings call: Verona Pharma reports Q1 2024 results, eyes COPD market
Investing.com· 3 days agoVerona Pharma (NASDAQ: VRNA ) has announced its first quarter 2024 financial results, highlighting...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Verona...
Benzinga· 3 days agoPDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT /
Varenicline Leads in Helping Smokers Kick the Habit, Study
Medscape· 3 days agoMost smokers do successfully quit after their first attempt. Switching patients from nicotine...
Smoking on oxygen killed 3 York countians this year. A $4.45 device might have saved them
Hanover Evening Sun via Yahoo News· 5 days ago"Typically, but not all the time, people who are on supplemental oxygen have a respiratory problem,...
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoInsmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript May 9, 2024 Insmed Incorporated...
Viemed Healthcare (VMD) to Release Earnings on Tuesday
ETF DAILY NEWS· 6 days agoViemed Healthcare (NASDAQ:VMD – Get Free Report) is scheduled to announce its earnings results before the market opens on Tuesday, May 7th. Viemed Healthcare has set its Q1 2024 guidance at ...
Theravance Biopharma to Participate in an Upcoming Investor Conference
FOX21 Colorado Springs· 3 days agoTheravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ Monday, May 20 at 11:30 AM EDT (8:30 ...
Pulmonary hypertension: Dietary changes may help with treatment, study finds
MedicalNewsToday via AOL· 4 days agoResearchers say dietary changes that limit the amino acids glutamine and serine may help slow...
The Interplay: Key Decisions at the Intersection of Antitrust & Life Sciences - April 2024 | JD...
JD Supra· 5 days agoThis week, the FTC continued its intense regulatory focus on pharmaceutical patents listed in the FDA’s Orange Book. As reported in earlier editions of The Interplay, the FTC issued a policy ...
ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of...
Benzinga· 5 days agoASLAN Pharmaceuticals ASLN, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, will today ...